Live

Emergent BioSolutions Inc. Common (EBS) congressional disclosures

Sector not mapped · coverage Jan 10, 2025–Jan 10, 2025

Email me the next EBS filing — free
Tracked disclosures
1
Lawmakers
1
Reported purchase / sale rows
0 / 1A disclosure count, not congressional market sentiment

Estimated market comparison · not an official filing fact

Available with Pro

Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.

Disclosure alert preview

Based on a real public filing

Sale

Steve Cohen

EBSEmergent BioSolutions Inc. Common

$1K - $15K

Traded
Dec 11, 2024
Filed
Jan 10, 2025
Disclosure delay
30 days
Reported owner
Not normalized

This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Aug 13, 2026.

Official filing

EBS congressional trades snapshot

This page summarizes public STOCK Act disclosures involving EBS. It is useful for seeing which lawmakers reported EBS transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Jan 10, 2025

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the EBS congressional trade page shows

Congressional Trader tracks 1 public STOCK Act disclosures for EBSacross 1 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent EBS filing shown here was filed on Jan 10, 2025 by Steve Cohen as a sale. Related lawmakers include Steve Cohen.

Top lawmakers for EBS

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans

FAQ

Which lawmakers traded EBS?

Recent EBS disclosures include Steve Cohen.

What is the buy/sell mix for EBS?

The visible sample currently shows 0 purchases and 1 sales or partial sales.

Should I trade based on EBS disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.